BSEShelter Pharma LtdLowPositive
Announced Tue, 19 May · 12:57 IST

Intimation under Regulation 30 of SEBI (LODR) Regulation, 2015- Continuous Positive Customer Feedback on Company Products.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.8%1-day move
₹30.56
prior close
₹30.79
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+2.8-1.8+1.4+1.4+0.2+3.5+5.4-1.8-8.3-7.1
Up moveDown movePending
AI summary

Shelter Pharma has filed a Regulation 30 disclosure informing BSE that it is receiving ongoing positive customer feedback across e-commerce platforms and its official website. The feedback pertains to both human and animal healthcare (veterinary) products, citing effectiveness, quality, and reliability. The company states this reflects its focus on research, quality standards, and customer satisfaction, and claims it enhances brand credibility, market presence, and long-term growth. The company itself has designated the event as 'material' in terms of goodwill and business visibility.

Likely market impact

This is a qualitative, non-quantifiable disclosure with no specific numbers, financial impact, or new contracts mentioned. It carries limited informational value for investors and should not be treated as a material stock-moving event.